155 related articles for article (PubMed ID: 16797205)
1. Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.
Yrjänäinen H; Hytönen J; Söderström KO; Oksi J; Hartiala K; Viljanen MK
Microbes Infect; 2006 Jul; 8(8):2044-51. PubMed ID: 16797205
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
[TBL] [Abstract][Full Text] [Related]
3. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
[TBL] [Abstract][Full Text] [Related]
4. Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice.
Yegutkin GG; Hytönen J; Samburski SS; Yrjänäinen H; Jalkanen S; Viljanen MK
J Immunol; 2010 May; 184(9):5112-20. PubMed ID: 20357256
[TBL] [Abstract][Full Text] [Related]
5. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
[TBL] [Abstract][Full Text] [Related]
6. Arthritogenicity of Borrelia burgdorferi and Borrelia garinii: comparison of infection in mice.
Craig-Mylius KA; Lee M; Jones KL; Glickstein LJ
Am J Trop Med Hyg; 2009 Feb; 80(2):252-8. PubMed ID: 19190223
[TBL] [Abstract][Full Text] [Related]
7. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.
Moody KD; Adams RL; Barthold SW
Antimicrob Agents Chemother; 1994 Jul; 38(7):1567-72. PubMed ID: 7979290
[TBL] [Abstract][Full Text] [Related]
9. Seronegative Lyme arthritis caused by Borrelia garinii.
Dejmková H; Hulínska D; Tegzová D; Pavelka K; Gatterová J; Vavrík P
Clin Rheumatol; 2002 Aug; 21(4):330-4. PubMed ID: 12189466
[TBL] [Abstract][Full Text] [Related]
10. The outcome of Lyme borreliosis in children.
Aberer E; Kehldorfer M; Binder B; Schauperi H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.
Kannian P; McHugh G; Johnson BJ; Bacon RM; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Dec; 56(12):4216-25. PubMed ID: 18050219
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
[TBL] [Abstract][Full Text] [Related]
13. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
14. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
Keane-Myers A; Nickell SP
J Immunol; 1995 Feb; 154(4):1770-6. PubMed ID: 7836761
[TBL] [Abstract][Full Text] [Related]
15. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
Infection; 1996; 24(1):9-16. PubMed ID: 8852456
[TBL] [Abstract][Full Text] [Related]
16. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
Keane-Myers A; Maliszewski CR; Finkelman FD; Nickell SP
J Immunol; 1996 Apr; 156(7):2488-94. PubMed ID: 8786309
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
18. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
[TBL] [Abstract][Full Text] [Related]
19. The effect of UV irradiation on infection of mice with Borrelia burgdorferi.
Brown EL; Ullrich SE; Pride M; Kripke ML
Photochem Photobiol; 2001 May; 73(5):537-44. PubMed ID: 11367577
[TBL] [Abstract][Full Text] [Related]
20. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P
Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
